Clinical Trial Update: Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating bromfenac ophthalmic solution in subjects with diffuse diabetic macular edema refractory to laser therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bromfenac Ophthalmic Solution (bromfenac sodium)

Snippet

Sponsor: Ophthalmic Consultants of Boston | Conditions: Diabetic Macular Edema | Phase 1 | Status: UNKNOWN